CUMYL-PINACA
Systematic (IUPAC) name | |
---|---|
1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1400742-15-5 |
Chemical data | |
Formula | C22H27N3O |
Molar mass | 349.5 g/mol |
| |
|
CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1]
Legal status
Sweden's public health agency suggested to classify CUMYL-PINACA as hazardous substance on November 10, 2014.[2]
See also
References
- ↑ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.